Insulet estimated that its total addressable market for automated insulin delivery will grow to a $9bn market value by 2028.
While the 2026 J.P. Morgan Healthcare Conference has thus far failed to yield any major M&A deals for the industry, Medtronic believes the time is ripe for buyouts. | While the 2026 J.P. Morgan ...
StockStory.org on MSN
Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)
With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...
Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback